Skip to content

Author

O. Dereure

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Immune-related adverse events with mogamulizumab in cutaneous T-cell lymphoma: A multicentre study.

BACKGROUND Mogamulizumab, an anti-CCR4 monoclonal antibody used in advanced mycosis fungoides (MF) and Sezary syndrome (SS), also depletes regulatory T cells, potentially leading to immune-related adverse events (irAEs). Unlike mogamulizumab-associated rash (MAR), other irAEs remain poorly documented to date. OBJECTI...

David Neubauer, P. Palassin, C. Ram-Wolff et al. · 0 citations
Case report Open access Oct 2026

Inflammatory rheumatic diseases under mogamulizumab: a multicenter series of 11 cases.

BACKGROUND Mogamulizumab (MOGA), an anti-CCR4 monoclonal antibody for mycosis fungoides (MF) and Sézary syndrome (SS), can trigger immune-mediated complications, such as rashes or endocrine disorders. Rheumatological manifestations are rare. OBJECTIVES To describe cases of inflammatory rheumatism (IR) induced or wors...

Arno Wahler, S. Guignard, G. Quereux et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.